YDR1
YDR1 is a potent PROTAC SMARCA2 degrader, with the DC50 of 7.7 nM. YDR1 plays an important role in SMARCA4 mutant cancers (Sturcture Note: (Blue: Cereblon ligand , Black: linker; Pink: SMARCA2 ligand (HY-44012B) ).
Product Specifications
CAS Number
2951015-31-7
UNSPSC
12352005
Target
Epigenetic Reader Domain; PROTACs
Type
Reference compound
Related Pathways
Epigenetics; PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ydr1.html
Purity
98.03
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N(C1CCC(NC1=O)=O)C2=O)C3=C2C=CC(N4CCN(CC5CCN(C6=C(F)C=C(CN7CCN(C8=C(N)N=NC(C9=C(O)C=CC=C9)=C8)CC7)C=C6)CC5)CC4)=C3
Molecular Formula
C44H49FN10O5
Molecular Weight
816.92
References & Citations
[1]Sasikumar Kotagiri, et al. Discovery of Novel, Potent and Orally Bioavailable SMARCA2 PROTACs with Synergistic Anti-tumor Activity in Combination with KRAS G12C Inhibitors. bioRxiv [Preprint]. 2024 Aug 26:2024.08.23.608456.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx442632 100 µg
HLA Class II Histocompatibility Antigen Gamma Chain (CD74) Antibody (APC)
Sign In for Pricing
View Details 
E53A07442 50 µg
Recombinant Human IL17BR / IL17RB / IL-17 Receptor B Protein (His tag)
Sign In for Pricing
View Details